References
- Berry LM, Zhao Z. (2008). An examination of IC50 and IC50-shift experiments in assessing time-dependent inhibition of CYP3A4, CYP2D6 and CYP2C9 in human liver microsomes. Drug Metab Lett 2:51–9
- Brøsen K, Skjelbo E, Rasmussen BB, et al. (1993). Fluvoxamine is a potent inhibitor of cytochrome P4501A2. Biochem Pharmacol 24:1211–14
- Cao YP, Gao C, Sun JH, et al. (1996). Study on pharmacological effects of Huanglianjiedu Tang extract. J China Pharmaceut Univ 27:605–8
- Foster BC, Vandenhoek S, Hana J, et al. (2003). In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products. Phytomedicine 10:334–42
- Grimm SW, Einolf HJ, Hall SD, et al. (2009). The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of America. Drug Metab Dispos 37:1355–70
- Guo Y, Li F, Ma X, et al. (2011). CYP2D plays a major role in berberine metabolism in liver of mice and humans. Xenobiotica 41:996–1005
- Hutzler JM, Cook J, Fleishaker JC. (2011). Drug-drug interactions: designing development programs and appropriate product labeling. In: Bonate PL, Howard DR, eds. Pharmacokinetics in drug development. Advances and applications, vol. 3. New York (NY): Springer, 21–56
- Kim MJ, Kim H, Cha IJ, et al. (2005). High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 19:2651–8
- Lee JY, Lee SY, Oh SJ, et al. (2012). Assessment of drug-drug interactions caused by metabolism-dependent cytochrome P450 inhibition. Chemico-Biol Interact 198:59–6
- Lee KS, Kim SK. (2013). Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions. J Appl Toxicol 33:100–8
- Lee SY, Lee JY, Kang W, et al. (2013a). In vitro and in vivo assessment of cytochrome P450-mediated herb-drug interaction of ssang-hwa-tang. Food Chem 136:450–7
- Lee SY, Lee JY, Kang W, et al. (2013b). Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang. Food Chem Toxicol 51:343–9
- Lin JH, Lu AY. (1998). Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet 35:361–90
- Ogilvie BW, Usuki E, Yerino P, Parkinson A. (2008). In vitro approaches for studying the inhibition of drug-metabolizing enzymes and identifying the drug-metabolizing enzymes responsible for the metabolism of drugs (Reaction Phenotyping) with emphasis on cytochrome P450. In: Rodrigues AD, ed. Drug-drug interactions. New York (NY): Informa Healthcare USA Inc., 231–358
- Perloff ES, Mason AK, Dehal SS, et al. (2009). Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50 shift approach facilitates kinact assay design. Xenobiotica 39:99–112
- Venkataramanan R, Komoroski B, Strom S. (2006). In vitro and in vivo assessment of herb drug interactions. Life Sci 78:2105–15